Cargando…
N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis
Silicosis is a lethal pneumoconiosis disease characterized by chronic lung inflammation and fibrosis. The present study was to explore the effect of against crystalline silica (CS)-induced pulmonary fibrosis. A total of 138 wild-type C57BL/6J mice were divided into control and experimental groups, a...
Autores principales: | Huang, Huaping, Chen, Mingjing, Liu, Feng, Wu, Haifeng, Wang, Jie, Chen, Jialiang, Liu, Meihua, Li, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639458/ https://www.ncbi.nlm.nih.gov/pubmed/31273057 http://dx.doi.org/10.1042/BSR20190681 |
Ejemplares similares
-
Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function
por: Guo, Xiuzhi, et al.
Publicado: (2020) -
Endothelial glycocalyx injury is involved in heatstroke-associated coagulopathy and protected by N-acetylcysteine
por: Peng, Na, et al.
Publicado: (2023) -
538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis
por: Demot, Bernard, et al.
Publicado: (2021) -
Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016) -
Lipopolysaccharides promote pulmonary fibrosis in silicosis through the aggravation of apoptosis and inflammation in alveolar macrophages
por: Tan, Shiyi, et al.
Publicado: (2020)